Shape Therapeutics logo

Shape Therapeutics Funding & Investors

Seattle, WA

Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.

shapetx.com

Total Amount Raised: $147,500,000

Shape Therapeutics Funding Rounds

  • Series B

    $112,000,000

    Series B Investors

    Breton Capital Management
    Decheng Capital
    Willett Advisors
    Mission BioCapital
    New Enterprise Associates (NEA)
    Ling Wong
  • Series A

    $35,500,000

    Series A Investors

    New Enterprise Associates (NEA)
    CureDuchenne Ventures
    Tectonic Capital
    Mission BioCapital
    Ling Wong
Funding info provided by Diffbot.